Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and safety of S201086/GLPG1972 in knee osteoarthritis
2017-004581-10Phase 2Completed
- Sponsor
- Servier
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of GLPG1972 in osteoarthritis (OA) (4 arms), sponsored by Servier. Primary endpoint: Cartilage thickness of the central medial tibiofemoral compartment (cMTFC) of the target knee. Started Apr 2018; status: completed.
02
Drugs
GLPG1972
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on 2017-004581-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004581-10.